Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin and social approach in social phobia
DRKS00000403Phase 4Not yet recruiting
- Sponsor
- RWTH Aachen University
- Start
- May 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of oxytocin in Social Anxiety Disorder (SAD), sponsored by RWTH Aachen University. Planned start May 2010; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on DRKS00000403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000403.